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Abstracts / International Journal of Surgery 36 (2016) S31eS132S32Results: The FTM tremor scores at 6-months and 1-year showed statisti-
cally signiﬁcant reduction in both conventional and DTI-guided groups.
(P<0.05) The DTI-guided group showed statistically signiﬁcant improve-
ment of tremor control, compared with conventional group in 1 year.
(P<0.05) The x, y and z co-ordinates in both groups showed comparable
mean values. (P>0.05).
Conclusions: DTI-guided DBS improves upper limb tremor control with
comparable result of active electrode positioning. DTI may be considered
as a future radiological guidance to improve long-term therapeutic effect.http://dx.doi.org/10.1016/j.ijsu.2016.08.043
0555: PLATELET-RICH-PLASMA INJECTIONS FOR THE TREATMENT OF
RESISTANT TROCHANTERIC PAIN
N. Blucher*, S. Nahas, V. Bonatsos, A. Patel, K. Sarraf, V. Vedi. Hillingdon
Hospital NHS Trust, London, UK.
Introduction: Platelet-Rich-Plasma(PRP) contains and releases a high
concentration of activated platelet derived growth factors which is
believed to stimulate the body's natural healing response in areas of
inﬂamed tissue. PRP injections are used in many tendinopathies and in-
ﬂammatory conditions,but there is a lack of clinical studies and trials in the
treatment of trochanteric pain.We investigated whether PRP injections
improve symptoms of resistant trochanteric pain.
Methods: The prospective study included 88 patients with trochanteric
bursitis resistant to steroid therapy and physiotherapy.PRP was prepared
using a standardised technique.Patient demographics were documented.
Pain scores(0-10),EQ-5D Health Domain,Utility and VAS scores,Hip
Disability and Osteoarthritis Outcome Scores(HOOS) were recorded pre
and post PRP injection.
Results: The mean age was 60(27-83),male to female ratio 1:4 and BMI
26(20-35).Duration of symptoms ranged from 3-120months.20% of pa-
tients reported moderate and 78% severe symptoms.Pain scores decreased
from 8.1 pre-injection to 4.6 post-injection(p<0.0001).69% of patients had
a successful outcome(Excellent/good/satisfactory).Both EQ-5D Utility and
EQ-5D VAS scores improved after the PRP injection (p<0.001)as did HOOS
scores(p<0.01).
Conclusions: This is the largest clinical study into PRP for treatment of
trochanteric pain.We have shown promising results and good outcomes in
both subjective and objective scoring.PRP injections should be considered
in the management of this condition.http://dx.doi.org/10.1016/j.ijsu.2016.08.044
0560: THE ASSOCIATION BETWEEN SODIUM FLUCTUATIONS AND MOR-
TALITY IN SURGICAL PATIENTS REQUIRING INTENSIVE CARE
R. Goodson 1,*, D. Marshall 1, J. Salciccioli 1, M. Pimentel 2, K. Sun 1,
L. Anthony Celi 3, J. Shalhoub 4. 1 Imperial College School of Medicine,
Imperial College London, London, UK; 2 Institute of Biomedical Engineering,
Department of Engineering Science, University of Oxford, UK; 3Beth Israel
Deaconess Medical Centre, Division of Pulmonary, Critical Care, and Sleep
Medicine, Boston, USA; 4 Section of Vascular Surgery, Department of Surgery
and Cancer, Imperial College London., UK.
Aim: Previous reports have demonstrated a relationship between serum
sodium ﬂuctuations and mortality in surgical critically ill patients. Our aim
was to assess the association between sodium ﬂuctuations and mortality
in a large population of adult surgical patients requiring intensive care.
Methods: A retrospective analysis of critically ill surgical patients from the
Multi-Parameter Intelligent Monitoring in Intensive Care database. The
associations between sodium ﬂuctuations and 28-day mortality were
assessed usingmultivariable logistic regression. Dysnatraemiawas deﬁned
as a sodium concentration upon ICU admission outside physiologic range
(135e145 mmol/L).
Results: A total of 8600 subjects were included in the analysis. Fluctua-
tions in serum sodium were associated with 28-day mortality (adjustedodds ratio (OR) per 1 mmol/L change: 1.10 (95%CI 1.08-1.13)) in dysna-
traemia. In subjects who remained normotraemic there was an association
between ﬂuctuation in sodium value and 28-day mortality (adjusted OR
1.13, 95%CI 1.10 e 1.16; p < 0.001). Subjects with dysnatraemia were more
likely to be dead at 28-days (17% vs 7%; p<0.001).
Conclusions: Dysnatraemia is common in post-surgical patients admitted
to intensive care. Fluctuations of serum sodium, including patients with
normal sodium, were associated with an increase in 28-day mortality and
that dysnatraemia was associated with 28-day mortality.http://dx.doi.org/10.1016/j.ijsu.2016.08.045
0655: IMPACT OF PROXIMITY TO PLASTIC AND RECONSTRUCTIVE SER-
VICES ON THE GEOGRAPHICAL VARIATION IN IMMEDIATE BREAST
RECONSTRUCTION PRACTICES IN THE UNITED KINGDOM
N.A.C. Bakri*, A. Bottle, G. Fontana, D.J. Hadjiminas, S. Wood, D. Leff.
Imperial College Healthcare NHS Trust, London, UK.
Aim: This study aimed to investigate the impact of proximity to the
nearest specialist plastic and reconstructive services on the geographic
variation in the volume of immediate post-mastectomy breast recon-
struction (IBR).
Methods: HES data was interrogated to derive 10-year [2004-2013] rates
of expander implant-only, autologous latissimus dorsi (LD), LD-implant
and autologous (non-LD) IBR by UK NHS Trust. The distance to specialist
plastic and reconstructive surgery services was derived from the data
available on the BAPRAS website. Bivariate spearman correlation analysis
was conducted between 10-year reconstruction volume and distance to
plastic reconstructive services (signiﬁcance p<0.05).
Results: An inverse relationship was observed between distance and IBR
volume for all procedures. The strength of the inverse relationship was not
signiﬁcant for LD-implant (Rho¼ -.134, p¼0.084) moderately signiﬁcant for
implant-only (Rho¼ -.161, p<0.05) but highly signiﬁcant for autologous LD
(Rho¼ -.254, p<0.001) and free-ﬂap reconstructions (Rho¼ -.377, p<0.001).
Conclusion: As predicted, the inverse relationship between proximity and
IBR volume and the strength of this association especially for autologous
and free-ﬂap procedures suggests that distance to plastic and recon-
structive service may in explain some of the geographic variation in post-
mastectomy breast reconstruction. These implications are that patients
with easier proximity to plastic surgeons may receive more complex IBR
procedures.http://dx.doi.org/10.1016/j.ijsu.2016.08.046
0751: RENAL TRANSPLANT FIBROSIS AT ONE MONTH POST TRANSPLAN-
TATION IS A SIGNIFICANT INDICATOR OF GRAFT SURVIVAL AT ONE
YEAR POST TRANSPLANTATION
W. Ismail 1,*, M. Aswad 2, S. Hosgood 2, M. Nicholson 2. 1 Transplant Unit,
Leicester, UK; 2University of Leicester, UK.
Aim: Renal transplant ﬁbrosis process commonly starts early after trans-
plantation due to various causes. Several risk factors have been identiﬁed
such as young recipient age, presensitization, histo-incompatability, and
acute rejection episodes, especially vascular rejection episodes and re-
jections that occur late after transplantation
Methods: The study has been designed to identify ﬁve time points of the
renal transplant ﬁbrosis (pre-transplant,1 month , 3months, 6 months and
12 months) for 300 live donor renal transplant patients over 12 years
period between March 1997- august 2009. All samples have been stained
with red Pickering Sirius red stain and ﬁbrosis was quantiﬁed using Image
Pro. Digital computerised analysis system
Statistical analysis
Univariate linear regression was performed to explore the association
between ﬁbrosis at 1 month and graft survival, rejection and severity of
rejection
Abstracts / International Journal of Surgery 36 (2016) S31eS132 S33Results: Fibrosis quantity at 1 month is signiﬁcantly associated with graft
survival (p¼0.01 and 95%CI 0.02 to 0.14). Rejection and severity of rejection
were not found to be associated with ﬁbrosis at 1 month. (Rejection:
p¼0.74 and 95%CI -0.02 to 0.03). (Severity: p¼0.81 and 95%CI -0.05 to 0.04)
Conclusion: Renal transplant ﬁbrosis at 1 month post transplant is a
strong indicator of graft survival at 1 year post transplantation.http://dx.doi.org/10.1016/j.ijsu.2016.08.047SARS research & academic prize
0142: CONNEXIN AS A BIOMARKER FOR VENOUS ULCERATION
M. Kanapathy 1,*, A. Mosahebi 1, D. Becker 2, T. Richards 2. 1University
College London, London, UK; 2 Lee Kong Chian School of Medicine, Singapore,
Singapore.
Aim: Leg ulceration is a feared complication of venous insufﬁciency.
Cellular communication via Connexins(Cx) is crucial in wound healing,
upregulation of which is associated with poor wound healing. This study
aims to determine and compare the epidermal Cx levels across stages of
venous disease and further determine if Cx can be used as a biomarker for
risk of venous ulceration.
Method: Patients were assessed according to CEAP classiﬁcation:
C2(n¼10), C4(n¼8), and C6(n¼8). Paired 4mm punch biopsies of the skin
were taken above the ankle(pathological) and above the knee(control).
Tissues were stained for H&E and Immunohistochemistry for Cx43, Cx30
and Cx26.
Results: H&E revealed increased inﬂammation, loss of dermal architecture
and epithelial hyper-thickening with increasing CEAP
(C2:41.94±9.39mm,C4:106.34±24.3mm,C6:674.44±116.21mm, p<0.05).
Overall Cx expression similarly increased across CEAP grades(p<0.05).
Cx43 had highest expression (C2:2061.13,C4:4061.08,C6:11639.60,
p<0.0001). Cx26 had lesser expression in C2 and C4 but increased signif-
icantly in C6 (C2:120.21,C4:558.79,C6:11561.54, p<0.001), similarly Cx30
(C2:145.16,C4:268.88,C6:8286.29, p<0.0001). Signiﬁcant increased
expression of all Cx was seen early in the disease; C2vs.C6(p<0.005) and
C4vs.C6(p<0.005).
Conclusion: Cx proteins were expressed increasingly with disease pro-
gression which starts early in the disease, suggesting that skin is pre-
conditioned for poor wound healing prior to ulceration. Cx can be used as a
biomarker to identify patients that should be treated early.http://dx.doi.org/10.1016/j.ijsu.2016.08.242
0242: APPLICATION OF GOLD NANORODS IN CANCER THERANOSTICS
M. Singh*, E. Nabavi, Y. Zhou, H. Zhao, D. Ma, A.E.G. Cass, G.B. Hanna,
D.S. Elson. Hamlyn Centre for Robotic Surgery, Institute of Global Health
Innovation, Department of Surgery and Cancer, Imperial College London,
London, UK.
Aims: Gold nanoparticles can be utilised as photothermal therapeutic
agents because of their strongly enhanced absorption of near infrared light
(NIR) resulting in hyperthermia. We investigate the ﬂuorescence and
photothermal effect from gold nanorods (GNRs) in the diagnostics and
therapy (theranostics) of in vivo upper gastrointestinal adenocarcinoma.
Methods: GNRs were functionalised with a ﬂuorophore (Cy5.5 dye)
modiﬁed with anti-EGFR antibody. Tumour xenografts were established in
immunodeﬁcient mice by subcutaneous inoculation of human oesopha-
geal adenocarcinoma (FLO-1) cells. Functionalised GNRs were then rand-
omised to be administered either intratumourally (IT) or intravenously (IV)
into mice. Fluorescence imaging was performed to observe tumour site
contrast enhancement, followed by tumour irradiation by an 808 nm (NIR)
continuous wave laser for three minutes.
Results: In vivo, bright ﬂuorescence emissions were observed speciﬁcally
emanating from tumour sites, providing diagnostic information. NIR irra-
diation established clinically signiﬁcant hyperthermia in tumoursresulting in consistently successful tumour ablations which were
conﬁrmed histologically. Inductively coupled plasma mass spectrometry
revealed no evidence of harmful organ accumulation of gold.
Conclusions: Fluorescence imaging of GNRs that localise to cancerous
tissue enhances cancer diagnosis. With a single application of NIR light,
this minimally invasive and clinically translatable technique can effectively
and safely induce irreversible tumour photodestruction.http://dx.doi.org/10.1016/j.ijsu.2016.08.2430521: TRO40303 REDUCES MITOCHONDRIAL INJURY AND AMELIO-
RATES EXPERIMENTAL ACUTE PANCREATITIS
M. Ahsan Javed 1,*, L. Wen 1, M. Awais 1, M. Chvanov 1, T. Bordet 2,
M. Michaud 2, S. Schaller 2, R. Pruss 2, A. Tepikin 1, D. Criddle 1, R. Sutton 1.
1NIHR Liverpool Pancreas Biomedical Research Unit, Liverpool, UK;
2 TROPHOS, Marseille, France.
Introduction: Mitochondrial permeability transition pore (MPTP) inhibi-
tion is a promising therapeutic strategy for treatment of acute pancreatitis
(AP). We investigated the effects of TRO40303on MPTP opening and ne-
crosis in pancreatic acinar cells (PACs) and evaluated its efﬁcacy in
experimental AP (EAP).
Methods: Mitochondrial membrane potential (DjM; TMRM), cytosolic
Ca2+ levels ([Ca2+]C; Fluo-4) and necrosis (PI) were evaluated in freshly
isolated murine and human PACs in the presence and absence of bile acid
(TLCS) or fatty acid ethyl ester (POAEE) using confocal microscopy. EAPwas
induced by intraperitoneal (IP) caerulein injections, retrograde pancreatic
ductal TLCS infusion or IP injections of palmitoleic acid and ethanol.
Liposomal TRO40303 was given post AP induction. AP was assessed by
standard biomarkers and blinded histopathology.
Results: TRO40303 protected loss of DjM induced by 500 mM TLCS or 100
mM POAEE in isolated PAC and improved [Ca2+]C clearance. TRO40303
reduced necrosis in murine and human PACs (p<0.05). TR040303 signiﬁ-
cantly reduced serum amylase, pancreatic trypsin, pancreatic and lung
myeloperoxidase and histopathological scores in all models of EAP.
Conclusion: TRO40303 protects mitochondria, reduces necrosis and
ameliorates the severity of three different models of EAP. TR040303 is a
candidate drug for the treatment of human AP.http://dx.doi.org/10.1016/j.ijsu.2016.08.2441122: FIELD CANCERISATION IN COLORECTAL CANCER: CHARACTERISA-
TION OF THE GENE EXPRESSION PROFILE OF THE MUCOSAL FIELD
AROUND COLORECTAL CANCERS AND POLYPS
A. Patel 1,*, Y. Wang 1, J. Moore 1, G. Tripathi 1, N. Williams 2,
R. Arasaradnam1. 1University of Warwick, Coventry, UK; 2University
Hospitals of Coventry and Warwickshire NHS Trust, Coventry, UK.
Aim: Field cancerisation describes genetic changes in the macroscopically
normal colonic mucosa (MNM) around a cancer which render it prema-
lignant without morphological change. This study aimed to characterise
the gene expression proﬁle in the MNM around cancer and polyps
compared to control subjects.
Methods: Subjects (n¼15) were recruited and mucosal pinch biopsies
taken. A two channel micro-array experiment was performed (SurePrint
G3 Human Gene Expression 8x60K Gene Expression array). Genes (>1.5
fold different, p value of<0.05) were selected and analysed using PANTHER
bioinformatics software.
Results: In total, 1665 genes were differentially expressed. The MNM
around polyps demonstrated differential gene expression of genes
involved in cell adhesion, cell morphology and cellular process. In com-
parison, genes responsible for the immune response, antigen processing
and natural killer cell activation (fold enrichment >5, p<0.001) were found
with transition to cancer. Comparing cancer to polyp identiﬁed genes that
participate in cell signalling, protein degradation and microtubule binding
(fold enrichment 3.01, p<0.001: 2.66, P<0.001 and 3.62, p<0.001,
respectively).
